">

Thursday, April 15, 2010

 

FDA approves J&JPRD's PANCREAZE NDA

Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and ...

# posted by (hris @ 5:20 AM
Comments: Post a Comment

Links to this post:

Create a Link



<< Home
Health blogs Health Blogs